AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32933960 — intervention group
Group type: COMPARATOR
Intervention: Behaviour Change Techniques (BCTs) in control groups
Number of subjects: 86
Study 32933960 — intervention group
Group type: EXPERIMENTAL
Intervention: Most common BCTs in intervention groups
Number of subjects: 86
Study 32933960 — intervention group
Group type: COMPARATOR
Intervention: Most common BCTs in control groups
Number of subjects: 86
Study 32933960 — intervention group
Group type: EXPERIMENTAL
Intervention: Identifiable BCTs
Number of subjects: 86
Study 36691203 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health education on iron and folic acid supplementation (IFAS)
Number of subjects: 1205
Study 32665431 — intervention group
Group type: EXPERIMENTAL
Intervention: ERIC and/or SOFIA
Number of subjects: 66
Study 32665431 — intervention group
Group type: COMPARATOR
Intervention: Control devices
Number of subjects: 66
Study 35682239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer prevention program delivered by community health workers (CHWs); education by trained CHWs, telephone counseling once a month for 6 months, individual meetings, and CD-ROM with conversation scenarios.
Number of subjects: 0
Study 35682239 — intervention group
Group type: COMPARATOR
Intervention: Control group provided educational materials related to breast and cervical cancers and a booklet on mammography and Pap test.
Number of subjects: 0
Study 32369545 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dietary fibers (TDF)
Number of subjects: 107377
Study 32369545 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble fibers (SF)
Number of subjects: 107377
Study 32369545 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoluble fibers (IF)
Number of subjects: 107377
Study 32369545 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fiber intake from fruit
Number of subjects: 107377
Study 33542275 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Ecologic Barrier)
Number of subjects: 40
Study 33542275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36427054 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential dual-task measures of listening effort with varying signal-to-noise ratios (SNR)
Number of subjects: 40
Study 36427054 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported listening effort
Number of subjects: 40
Study 34851960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively demanding task to deplete self-control
Number of subjects: 0
Study 34851960 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 613425329 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg
Number of subjects: 61
Study 613425329 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 61
Study 613425329 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 61
Study 35020250 — intervention group
Group type: EXPERIMENTAL
Intervention: Restylane (Group A) - Superficial injection (Group A1)
Number of subjects: 100
Study 35020250 — intervention group
Group type: EXPERIMENTAL
Intervention: Restylane (Group A) - Deep injection (Group A2)
Number of subjects: 100
Study 35020250 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishumei (Group B) - Superficial injection (Group B1)
Number of subjects: 100
Study 35020250 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishumei (Group B) - Deep injection (Group B2)
Number of subjects: 100
Study 35020250 — intervention group
Group type: COMPARATOR
Intervention: Both fillers
Number of subjects: 100
Study 32339059 — intervention group
Group type: EXPERIMENTAL
Intervention: Online social support messages
Number of subjects: 8343
Study 32339059 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning analysis of messages
Number of subjects: 8343
Study 616119607 — intervention group
Group type: EXPERIMENTAL
Intervention: PASCAL laser PRP
Number of subjects: 44
Study 616119607 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTRS laser PRP
Number of subjects: 44
Study 616119607 — intervention group
Group type: COMPARATOR
Intervention: IVR alone
Number of subjects: 44
Study 35197212 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower GNRI group (≤98)
Number of subjects: 300
Study 35197212 — intervention group
Group type: COMPARATOR
Intervention: Higher GNRI group (98<)
Number of subjects: 300
Study 35197212 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model of GNRI and ARC‐HBR
Number of subjects: 300
Study 35197212 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower GNRI and ARC‐HBR positivity
Number of subjects: 300
Study 32412884 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Drink (ED) intake 15 minutes before exercise
Number of subjects: 29
Study 32412884 — intervention group
Group type: COMPARATOR
Intervention: Placebo protocol (PP) - water intake 15 minutes prior to exercise
Number of subjects: 29
Study 36198322 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based VMAT forward dose calculations using a convolutional neural network trained on dose of individual multi-leaf-collimator VMAT segments.
Number of subjects: 17
Study 36198322 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based VMAT forward dose calculations on previously unseen IMRT patients.
Number of subjects: 17
Study 34535091 — intervention group
Group type: EXPERIMENTAL
Intervention: Germicidal ultraviolet (GUV) light intervention
Number of subjects: 320
Study 34535091 — intervention group
Group type: COMPARATOR
Intervention: Control (standard infection control measures)
Number of subjects: 320
Study 34535091 — intervention group
Group type: EXPERIMENTAL
Intervention: GUV light intervention
Number of subjects: 320
Study 33518152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary arsenic supplementation (0.95, 20.78, 40.67, and 60.25 mg/kg)
Number of subjects: 512
Study 33518152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary arsenic supplementation
Number of subjects: 512
Study 32041583 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (EC) - SOC plus intensified TB case finding and active tracing
Number of subjects: 14963
Study 32041583 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care plus Xpert (EC+X) - SOC plus intensified TB case finding, active tracing, and Xpert
Number of subjects: 14963
Study 32041583 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) - no additional interventions
Number of subjects: 14963
Study 32041583 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EC+X to SOC
Number of subjects: 14963
Study 32041583 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EC+X to EC
Number of subjects: 14963
Study 35366138 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping applied during 2 cycles for 2–3 weeks
Number of subjects: 16
Study 35366138 — intervention group
Group type: COMPARATOR
Intervention: No specific therapy (control group)
Number of subjects: 16
Study 35186274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pepsi
Number of subjects: 36
Study 35186274 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirinda
Number of subjects: 36
Study 35186274 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva
Number of subjects: 36
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolisable energy intake (MEI)
Number of subjects: 300
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilisation efficiency for egg production (ko)
Number of subjects: 300
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilisation efficiency (kt)
Number of subjects: 300
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Net energy requirement for weight gain (WG)
Number of subjects: 300
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg mass (EM)
Number of subjects: 300
Study 32594949 — intervention group
Group type: EXPERIMENTAL
Intervention: Retained energy (RE)
Number of subjects: 300
Study 35507945 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 656
Study 35507945 — intervention group
Group type: COMPARATOR
Intervention: venetoclax and azacitidine (ven/aza)
Number of subjects: 656
Study 33431807 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial cognitive task 'Tetris' with mental rotation instructions
Number of subjects: 41
Study 33431807 — intervention group
Group type: COMPARATOR
Intervention: Podcast (active control)
Number of subjects: 41
Study 34253433 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous prodding reduction and K‐wire fixation via sinus tarsi approach (PPRKF)
Number of subjects: 51
Study 34253433 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 51
Study 34253433 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PPRKF and ORIF
Number of subjects: 51
Study 33743650 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP plus physiotherapy
Number of subjects: 314
Study 33743650 — intervention group
Group type: COMPARATOR
Intervention: PRP
Number of subjects: 314
Study 34347057 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic Warning Labels (GWL) cigarette packs
Number of subjects: 357
Study 34347057 — intervention group
Group type: COMPARATOR
Intervention: Standard US pack
Number of subjects: 357
Study 34347057 — intervention group
Group type: COMPARATOR
Intervention: Blank pack
Number of subjects: 357
Study 36484428 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg for 13 weeks
Number of subjects: 90
Study 36484428 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 13 weeks
Number of subjects: 90
Study 33592849 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular exercise
Number of subjects: 0
Study 33592849 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32167240 — intervention group
Group type: EXPERIMENTAL
Intervention: Products A and B
Number of subjects: 30
Study 32167240 — intervention group
Group type: COMPARATOR
Intervention: Control X
Number of subjects: 30
Study 32167240 — intervention group
Group type: EXPERIMENTAL
Intervention: Product C
Number of subjects: 30
Study 32167240 — intervention group
Group type: COMPARATOR
Intervention: Control Y
Number of subjects: 30
Study 34726329 — intervention group
Group type: EXPERIMENTAL
Intervention: HM15136 (10-120 μg/kg)
Number of subjects: 56
Study 34726329 — intervention group
Group type: EXPERIMENTAL
Intervention: HM15136 (80 μg/kg)
Number of subjects: 56
Study 34726329 — intervention group
Group type: EXPERIMENTAL
Intervention: HM15136 (50 μg/kg or higher)
Number of subjects: 56
Study 34726329 — intervention group
Group type: EXPERIMENTAL
Intervention: HM15136
Number of subjects: 56
Study 34726329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 34100789 — intervention group
Group type: EXPERIMENTAL
Intervention: Low velocity loss (LVL) threshold at 15%
Number of subjects: 10
Study 34100789 — intervention group
Group type: EXPERIMENTAL
Intervention: High velocity loss (HVL) threshold at 30%
Number of subjects: 10
Study 32301204 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (1,000 mg/day)
Number of subjects: 20
Study 32301204 — intervention group
Group type: COMPARATOR
Intervention: Placebo (microcrystalline cellulose/day)
Number of subjects: 20
Study 35077818 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Specific Instrumentation (PSI)
Number of subjects: 77
Study 35077818 — intervention group
Group type: COMPARATOR
Intervention: Traditional cutting block techniques (Control)
Number of subjects: 77
Study 33573704 — intervention group
Group type: EXPERIMENTAL
Intervention: Total CCFN (H3)
Number of subjects: 40
Study 33573704 — intervention group
Group type: EXPERIMENTAL
Intervention: H3K36me3
Number of subjects: 40
Study 33573704 — intervention group
Group type: EXPERIMENTAL
Intervention: H3 citrulline
Number of subjects: 40
Study 32012409 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg tamsulosin only (Group-A)
Number of subjects: 140
Study 32012409 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tadalafil with tamsulosin (Group-B)
Number of subjects: 140
Study 34709770 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-1 collagen cone (CC)
Number of subjects: 30
Study 34709770 — intervention group
Group type: COMPARATOR
Intervention: Control (no collagen cone)
Number of subjects: 30
Study 33186772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 10 mg per day for 12 weeks
Number of subjects: 40
Study 33186772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34076329 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative event with counterfactual
Number of subjects: 466
Study 34076329 — intervention group
Group type: COMPARATOR
Intervention: Negative event only
Number of subjects: 466
Study 34076329 — intervention group
Group type: COMPARATOR
Intervention: Negative event with description
Number of subjects: 466
Study 34076329 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 466
Study 33289308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg/day
Number of subjects: 63
Study 33289308 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 63
Study 35469091 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (12 g/day)
Number of subjects: 60
Study 35469091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32317292 — intervention group
Group type: EXPERIMENTAL
Intervention: NY‐ESO‐1/ISCOMATRIX vaccine
Number of subjects: 110
Study 32317292 — intervention group
Group type: COMPARATOR
Intervention: ISCOMATRIX alone
Number of subjects: 110
Study 34480530 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative systemic chemotherapy
Number of subjects: 2150
Study 34480530 — intervention group
Group type: COMPARATOR
Intervention: Resection alone (control)
Number of subjects: 2150
Study 33884043 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EXP) focusing on interoceptive correlates
Number of subjects: 20
Study 33884043 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTR)
Number of subjects: 20
Study 33884043 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 34981548 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity, long-wavelength red light therapy (LLRT) (power 0.4 mW, wavelength 635 nm) twice per day for 3 min each session
Number of subjects: 105
Study 33984253 — intervention group
Group type: EXPERIMENTAL
Intervention: G80 (2 sets at 80% and 2 sets at 40% of 1 repetition maximum (1RM), 1 concentric second and 3 eccentric seconds controlled by a metronome)
Number of subjects: 50
Study 33984253 — intervention group
Group type: EXPERIMENTAL
Intervention: G40 (4 sets at 40% of 1RM, 1 s and 3 s controlled by a metronome)
Number of subjects: 50
Study 33984253 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 32654603 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-SA combined with NPWT (n=11)
Number of subjects: 25
Study 32654603 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (n=14)
Number of subjects: 25
Study 35870999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused CBT with positive memory module
Number of subjects: 135
Study 35870999 — intervention group
Group type: COMPARATOR
Intervention: Trauma-focused CBT without positive memory module
Number of subjects: 135
Study 35870999 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 135
Study 33905748 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical soft contact lenses (–6 D to +6 D in 2 D steps)
Number of subjects: 11
Study 33167111 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nail
Number of subjects: 37
Study 33167111 — intervention group
Group type: COMPARATOR
Intervention: Locking plate
Number of subjects: 37
Study 32977331 — intervention group
Group type: EXPERIMENTAL
Intervention: SCFP (Saccharomyces cerevisiae fermentation-based postbiotic)
Number of subjects: 60
Study 32977331 — intervention group
Group type: COMPARATOR
Intervention: PCON (control group without SCFP)
Number of subjects: 60
Study 32977331 — intervention group
Group type: EXPERIMENTAL
Intervention: SCFP
Number of subjects: 60
Study 32977331 — intervention group
Group type: COMPARATOR
Intervention: PCON
Number of subjects: 60
Study 32436390 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1605
Study 32436390 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 1605
Study 32436390 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR and SAVR
Number of subjects: 1605
Study 32436390 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural outcomes
Number of subjects: 1605
Study 32436390 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-procedural outcomes
Number of subjects: 1605
Study 33377160 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest tertile of baseline serum bicarbonate (23.1 ± 1.6 mmol/L)
Number of subjects: 296
Study 33377160 — intervention group
Group type: EXPERIMENTAL
Intervention: Each mmol/L decrease in serum bicarbonate
Number of subjects: 296
Study 35587779 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy meal-replacement plan (MRP) (∼810 kcal/day)
Number of subjects: 83
Study 35587779 — intervention group
Group type: COMPARATOR
Intervention: Exercise training
Number of subjects: 83
Study 35587779 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 83
Study 34508569 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 3 months
Number of subjects: 51
Study 32366328 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus Proactive Psychological Medicine (PPM)
Number of subjects: 0
Study 32366328 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 32366328 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus PPM
Number of subjects: 0
Study 35392020 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-channel tDCS, Functional electrical stimulation, Saebo Flex Training, and conventional rehabilitation
Number of subjects: 0
Study 35392020 — intervention group
Group type: COMPARATOR
Intervention: Sham multi-channel tDCS, FES, training with SaeboFlex, and conventional physiotherapy intervention
Number of subjects: 0
Study 32792245 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) combined with NSAIDs
Number of subjects: 80
Study 32792245 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs alone (Control group)
Number of subjects: 80
Study 33047637 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid autoimmunity group (n = 39)
Number of subjects: 85
Study 33047637 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 46)
Number of subjects: 85
Study 32073417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary prourokinase administration
Number of subjects: 0
Study 34144574 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the affected hemisphere and cathodal over unaffected hemisphere combined with repetitive peripheral nerve stimulation
Number of subjects: 19
Study 34144574 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS associated to repetitive peripheral nerve stimulation
Number of subjects: 19
Study 33392782 — intervention group
Group type: EXPERIMENTAL
Intervention: 940 nm laser diode irradiation
Number of subjects: 30
Study 32993574 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy and cetuximab
Number of subjects: 315
Study 32993574 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy and cetuximab
Number of subjects: 315
Study 35093013 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 10 mg
Number of subjects: 2466
Study 35093013 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 30 mg
Number of subjects: 2466
Study 35093013 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 60 mg
Number of subjects: 2466
Study 35093013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2466
Study 34922475 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote activity monitoring (RAM) system
Number of subjects: 179
Study 34922475 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RAM)
Number of subjects: 179
Study 32567433 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 13
Study 32567433 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 13
Study 35342790 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided PowerPoint tutorial on head and neck anatomy
Number of subjects: 178
Study 35342790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tutorial engagement)
Number of subjects: 178
Study 33032564 — intervention group
Group type: EXPERIMENTAL
Intervention: Online exercise programme and diet counselling on calcium and vitamin D.
Number of subjects: 116
Study 33032564 — intervention group
Group type: COMPARATOR
Intervention: Diet counselling only (Control group).
Number of subjects: 116
Study 36124913 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley bread (BB)
Number of subjects: 20
Study 36124913 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bread (OB)
Number of subjects: 20
Study 36124913 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-wheat bread (WWB)
Number of subjects: 20
Study 36124913 — intervention group
Group type: COMPARATOR
Intervention: White bread (WB)
Number of subjects: 20
Study 33589569 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-reduction group (ERG)
Number of subjects: 1021
Study 33589569 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation group (CSG)
Number of subjects: 1021
Study 33589569 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-reduction with calcium supplementation group (ER-CSG)
Number of subjects: 1021
Study 33589569 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1021
Study 35379311 — intervention group
Group type: EXPERIMENTAL
Intervention: Retromuscular Sugarbaker technique
Number of subjects: 0
Study 35379311 — intervention group
Group type: COMPARATOR
Intervention: Retromuscular keyhole technique
Number of subjects: 0
Study 35379311 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 34558301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (tweeting/retweeting health content 2 times/week for 6 months)
Number of subjects: 611